Tech Company Financing Transactions

Kailera Therapeutics Funding Round

On 10/1/2024, Kailera Therapeutics raised $400 million in Series A financing from Atlas Venture, Bain Capital Life Sciences and RTW Investments.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

890 Winter Street 220
Waltham, MA 02451
USA

Phone

Undisclosed

Website

www.kailera.com

Email Address

[email protected]

Overview

Advancing a broad pipeline of next-generation therapies for chronic weight management. Kailera Therapeutics is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Our experienced leadership team has a track record of building companies that deliver innovative, paradigm-shifting technologies, and is positioned to drive success, ensuring that our breakthroughs reach those who need them most.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ron Renaud

        

Chief Medical Officer

Scott Wasserman

        

Chief Operating Officer

Paul Burgess

        

Chief Technical Officer

Doug Bakan

        

VP - Human Resources

Paula Cloghessy

        

Browse more venture capital transactions:

Prev: 10/1/2024: Pluvion venture capital transaction
Next: 10/1/2024: Eon venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary